NDC Active Ingredient Ranibizumab

Active Ingredient Information

What is Ranibizumab?

A recombinant humanized monoclonal antibody fragment that binds VEGF-A to prevent its binding to VEGFR-1 and VEGFR-2 receptors. This activity reduces vessel permeability and angiogenesis in the treatment of neovascular age-related MACULAR DEGENERATION.

What is the usage for Ranibizumab?

This medication is used to treat certain serious eye conditions (such as age-related macular degeneration, macular edema, diabetic retinopathy). It is used to help prevent decreased vision and blindness. Ranibizumab works by slowing the growth of abnormal new blood vessels in the eye and decreasing leakage from these blood vessels.

How many products in the NDC database contain Ranibizumab?

The NDC database has 13 products with the active ingredient Ranibizumab. The following table lists all the products that have this active ingredient.

NDC Products with Ranibizumab

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
50242-078Proprietary Name: Susvimo RanibizumabInjection, SolutionIntravitrealGenentech, Inc.ACTIVE
50242-080Proprietary Name: Lucentis RanibizumabInjection, SolutionIntravitrealGenentech, Inc.ACTIVE
50242-082Proprietary Name: Lucentis RanibizumabInjection, SolutionIntravitrealGenentech, Inc.ACTIVE
50242-183Proprietary Name: RanibizumabSolutionGenentech, Inc.ACTIVE
64406-019Proprietary Name: Byooviz Ranibizumab-nunaInjection, SolutionIntravitrealBiogen Inc.ACTIVE
68225-123Proprietary Name: RanibizumabInjection, SolutionPatheon Italia S.p.a.ACTIVE
70114-440Proprietary Name: Cimerli Ranibizumab-eqrnInjection, SolutionIntravitrealCoherus Biosciences IncACTIVE
70114-441Proprietary Name: Cimerli Ranibizumab-eqrnInjection, SolutionIntravitrealCoherus Biosciences IncACTIVE
71082-110Proprietary Name: RanibizumabInjection, SolutionFrueh Verpackungstechnik AgACTIVE
71082-111Proprietary Name: RanibizumabInjection, SolutionFrueh Verpackungstechnik AgACTIVE
82775-100Proprietary Name: RanibizumabSolution, ConcentratePolpharma Biologics SaACTIVE
83832-110Proprietary Name: RanibizumabInjection, SolutionLabor Zollinger AgACTIVE
83832-111Proprietary Name: RanibizumabInjection, SolutionLabor Zollinger AgACTIVE
<